Bayer AG (OTCMKTS:BAYRY) – Investment analysts at Jefferies Group issued their FY2022 EPS estimates for Bayer in a research note issued to investors on Tuesday. Jefferies Group analyst J. Holford expects that the company will post earnings per share of $2.94 for the year.
Bayer (OTCMKTS:BAYRY) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. Bayer had a return on equity of 18.53% and a net margin of 10.88%.
Bayer (BAYRY) traded up $0.02 on Wednesday, hitting $31.82. The stock had a trading volume of 440,616 shares, compared to its average volume of 426,639. The company has a market capitalization of $105,070.00, a PE ratio of 27.91, a PEG ratio of 1.95 and a beta of 1.14. The company has a current ratio of 1.51, a quick ratio of 1.01 and a debt-to-equity ratio of 0.67. Bayer has a 1-year low of $26.98 and a 1-year high of $35.41.
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology.
Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.